スパロボまとめ速報
Unofficial fan site rounding up Super Robot Wars news.
srwmatome.com Entertainment & Media / News & Media
- Monthly visits
- 80.5K
- Down13.0%MoMOct 2026
- Public revenue
- Undisclosed
- No public revenue evidence yet
- Entry price
- Unknown
- No monthly subscription pricing
- Launched
- 18mo ago
- 2025-05-25 · Est.
Traffic
Marketing moves
Launches, search & content, referrals, promotionsX accounts@srwmatome
- スパロボXは異世界の割にあんま異世界感なかったね https://srwmatome.com/archives/21682.html
@srwmatome · 2026-11-16 · 12 likes · 1 reposts · 1,936 views
- 【スパロボY】種勢は種自由控えてるから どうしても基本性能落とす必要あるんだろうな https://srwmatome.com/archives/21678.html
@srwmatome · 2026-11-15 · 21 likes · 3 reposts · 12.9K views
- まぁスパロボ自体年季がある作品だから、新録できないキャラは代役なんか新録なしなんかね https://srwmatome.com/archives/21674.html
@srwmatome · 2026-11-14 · 35 likes · 7 reposts · 5,399 views
New product launchLaunch
May 25, 2025 · 18mo agoWebsite
Traffic sources
Oct 2026
Traffic breakdown
Channels
- Direct53%
- Referrals32%
- Organic Search13%
- Other1%
Countries
- Japan100%
Search
Domain authority —Domain registered 2025-05-25
| Keyword | Monthly volume |
|---|---|
| スパロボまとめ | 440 |
| スパロボy 攻略本 出ない | 220 |
| ”マジンガー信者” | 100 |
| スーパーロボット大戦y 水星の魔女 シナリオ 隔離されている | 70 |
| スパロボ速報 | 30 |
Traffic data: Vaneform
Pricing
Pricing page not identified yet, or no public pricing listed.
Pages & changes
Tracked since 2026-11-04
Key pages
Weekly snapshotsHome
srwmatome.com/ Snapshot 2026-11-05
Changes
Questions & evidence
- How much website traffic does スパロボまとめ速報 get?
- Vaneform estimates 80.5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
- What is スパロボまとめ速報 and what platforms does it support?
- スパロボまとめ速報 is catalogued under News & Media: Unofficial fan site rounding up Super Robot Wars news. Supported platforms: Web.
Related products in this category
Entertainment & Media / News & Media
These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.